SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-147717
Filing Date
2022-05-12
Accepted
2022-05-11 19:29:19
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d252057d10q.htm   iXBRL 10-Q 560651
2 EX-31.1 d252057dex311.htm EX-31.1 11245
3 EX-31.2 d252057dex312.htm EX-31.2 11251
4 EX-32.1 d252057dex321.htm EX-32.1 4490
5 EX-32.2 d252057dex322.htm EX-32.2 4424
  Complete submission text file 0001193125-22-147717.txt   3283677

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flac-20220331.xsd EX-101.SCH 34947
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flac-20220331_cal.xml EX-101.CAL 15606
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flac-20220331_def.xml EX-101.DEF 189954
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flac-20220331_lab.xml EX-101.LAB 226195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flac-20220331_pre.xml EX-101.PRE 228067
45 EXTRACTED XBRL INSTANCE DOCUMENT d252057d10q_htm.xml XML 379230
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39765 | Film No.: 22915254
SIC: 6770 Blank Checks